Cell debuts design changes and expanded scientific coverage
Leading Edge adds in depth analysis section
Cambridge, December 2, 2005- Cell, a scientific journal published by Elsevier imprint Cell Press, has launched a new section, called Leading Edge, which adds pages of analysis, commentary, and essays to the popular review formats—including full reviews, minireview, and previews—in each issue.
The new design maintains the journal’s classic look while incorporating features including an updated typeface, illustrations and graphics with a consistent style, and more color throughout.
“The Leading Edge section will feature in-depth analytical articles by science writers, and essays and commentaries by eminent scientists,” Cell Editor Emilie Marcus explains. “In a time of increasing scientific specialization, we feel a responsibility to support the progress of science by promoting interdisciplinary communication. All of our content and design changes will support these goals while maintaining Cell’s reputation for high standards of research and communicating conceptual scientific advances.”
The changes debut in the December 2, 2005 issue, which is freely available online, at www.cell.com/content/issue?volume=123&issue=5.
About Cell Press:
Cell Press an imprint of Elsevier, is committed to improving scientific communication through the publication of exciting biology research and reviews. Cell Press journals include the flagship journal Cell, Neuron, Immunity, Molecular Cell, Developmental Cell Cancer Cell, Current Biology, Structure , Chemistry & Biology, and the new journal Cell Metabolism, which launched in January 2005. Cell Press’s mission is to continue to publish and develop journals that deliver the highest possible intellectual rigor, promote community trust, and are widely disseminated.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Research Intelligence and ClinicalKey— and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. www.elsevier.com